Advancing scalable solid-state quantum computing from materials to quantum processors and simulators—this is the ambitious ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Artificial intelligence is revolutionizing enterprise software, enhancing automation, decision-making, and operational ...

NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating potent anti-tumor ...

As PODIUM celebrates its second anniversary amidst Art Basel Hong Kong, Observer caught up with Cheng to learn more about the ...

Zhejiang Langhua Pharmaceutical Co., Ltd. ('Langhua Pharmaceutical'), a wholly-owned subsidiary of Viva Biotech Holdings ('Viva Biotech'), underwent a cGMP (Current Good Manufacturing Practices) ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...

Future Prospects: The future of the UAE Loyalty Programs market is promising, driven by factors such as customer-centric strategies, data-driven insights, and the continued expansion of digital ...

The UK firm's lead project is CDK7-targeted GTAEXS617, currently in the phase 1/2 ELUCIDATE trial in advanced solid tumours, while Recursion has four candidates in phase 2 trials including REC-994 ...

Two LED lamps installed in the solar chamber simulated solar radiation, allowing solar photodecomposition to occur under controlled conditions. The BTEX solutions were prepared and diluted in ...